IRIS
CERRI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.502
EU - Europa 843
AS - Asia 780
SA - Sud America 105
AF - Africa 18
OC - Oceania 5
Totale 3.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.478
CN - Cina 385
IE - Irlanda 264
SG - Singapore 180
HK - Hong Kong 138
RU - Federazione Russa 136
DE - Germania 104
BR - Brasile 90
FI - Finlandia 84
IT - Italia 78
GB - Regno Unito 37
UA - Ucraina 36
CZ - Repubblica Ceca 19
SE - Svezia 19
CA - Canada 18
FR - Francia 17
VN - Vietnam 16
IN - India 14
AT - Austria 8
JP - Giappone 8
ES - Italia 7
AR - Argentina 6
BD - Bangladesh 6
BE - Belgio 6
IQ - Iraq 6
NL - Olanda 6
PL - Polonia 6
MA - Marocco 5
MU - Mauritius 5
MX - Messico 5
ZA - Sudafrica 5
AU - Australia 4
LT - Lituania 4
KR - Corea 3
TR - Turchia 3
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
GE - Georgia 2
LK - Sri Lanka 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
TJ - Tagikistan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.253
Salva come PNG Salva come JPEG
Città #
Chandler 289
Dublin 264
Dallas 168
Ashburn 146
Hong Kong 137
Beijing 114
Singapore 65
Boardman 58
Helsinki 54
Jacksonville 45
Princeton 45
Lawrence 44
Los Angeles 43
New York 43
Shanghai 37
Munich 36
Medford 33
Wilmington 30
Nanjing 23
The Dalles 20
Chicago 18
Redondo Beach 18
São Paulo 18
Moscow 17
Brno 16
Buffalo 15
Nanchang 14
Changsha 13
Milan 13
Shenyang 13
Washington 12
Pavia 11
Tianjin 11
Hebei 10
Rome 10
Turku 10
Fairfield 9
Hangzhou 9
Santa Clara 9
Atlanta 8
Jiaxing 8
Tokyo 8
Columbus 7
Düsseldorf 7
London 7
Nuremberg 7
Brussels 6
Denver 6
Norwalk 6
Seattle 6
Stockholm 6
Toronto 6
Warsaw 6
Boston 5
Brooklyn 5
Guangzhou 5
Montreal 5
Rio de Janeiro 5
Shijiazhuang 5
Chennai 4
Falls Church 4
Giessen 4
Hanoi 4
Ho Chi Minh City 4
Johannesburg 4
Manchester 4
New Delhi 4
Ningbo 4
Orem 4
Phoenix 4
Piscataway 4
Woodbridge 4
Florence 3
Las Vegas 3
Mexico City 3
Poplar 3
San Francisco 3
Wuhan 3
Xi'an 3
Ankara 2
Ann Arbor 2
Baku 2
Bratislava 2
Cairo 2
Calgary 2
Cambridge 2
Campinas 2
Carney 2
Caxias do Sul 2
Charlotte 2
Colombo 2
Des Moines 2
Elk Grove Village 2
Falkenstein 2
Guarulhos 2
Houston 2
Hải Dương 2
Kunming 2
Lahore 2
Mogi das Cruzes 2
Totale 2.179
Salva come PNG Salva come JPEG
Nome #
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction. 107
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 106
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease 103
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer 100
Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. 100
Postnatal development of Central Nervous System: anomalies in the formation of cerebellum fissures 94
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 92
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 91
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. 90
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease 88
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 87
Cell proliferation and death in the brain of active and hibernating frogs 85
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum 84
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease 83
The insect brain as a model to investigate the PCB effects. Changes of NOS-dependent NADPH diaphorase activity in Blattella germanica 78
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease 78
Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease 78
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 76
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 74
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease 74
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease 73
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity 71
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects 71
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease 71
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 71
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 70
Repurposing opportunities for Parkinson’s disease therapies 69
Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease 68
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 67
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 66
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine 65
Interactions of neurotransmitter systems during postnatal development of the rat hippocampal formation: effects of cisplatin 64
Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease 63
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease 63
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 62
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 60
Potential therapeutic effects of polyphenols in Parkinson's disease: In vivo and in vitro pre-clinical studies 60
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease 51
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 43
Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias 42
Peripheral-central neuroimmune crosstalk in parkinson’s disease: What do patients and animal models tell us? 39
Parkinson's Disease in Women and Men: What's the Difference? 35
Role of autophagy in Parkinson’s disease 34
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease 34
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 33
In vivo modeling of prodromal stage of Parkinson's disease 31
Investigation and Comparison of Active and Passive Encapsulation Methods for Loading Proteins into Liposomes 29
Parkinson’s disease 26
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 15
Totale 3.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 11 0 21 23 16 9 4
2021/2022189 0 1 3 0 1 5 2 11 10 0 33 123
2022/2023757 91 80 15 55 58 62 0 41 328 3 17 7
2023/2024362 54 50 14 15 27 96 20 22 6 14 28 16
2024/2025862 48 64 28 21 21 60 42 53 210 48 119 148
2025/2026774 134 118 207 194 121 0 0 0 0 0 0 0
Totale 3.314